http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019280051-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bafd351f34731ab47026eb2a4235017
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2433
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
filingDate 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abbbbbb2edbd0dc8fcecd264e09ff95a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa58b3395e1dd55c7c95b549b9804a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75e6e3d7a946e4cb2dfc01db0cd214dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b86018aa8ca2cd734839a9ce218b5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ef6b40f0c4eca161eeb804855b8ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a50813cc02695307db90592884b2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d399fee2e90f5bd4af20df781906862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef9ec15f007cc65965b576716960521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ddc10dbed1a40590351160ea3a17f8
publicationDate 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2019280051-A1
titleOfInvention Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
abstract Prosthetic heart valve devices for percutaneous replacement ofnative heart valves and associated systems and method are disclosed herein. A prosthetic heart valve device configured in accordance with a particular embodiment of the present technology can include an anchoring member having an upstream portion configured to engage with tissue on or near the annulus of the native heart valve and to deform in a non-circular shape to conform to the tissue. The device can also include a mechanically isolated valve support coupled to the anchoring member and configured to support a prosthetic valve. The device can further include an atrial extension member extending radially outward from the upstream portion of the anchoring member and which is deformable without substantially deforming the anchoring member. In some embodiments, the upstream portion of the anchoring member and the extension member may be deformed while the valve support remains sufficiently stable. 2130,2132 2120 2112 - }170a 170a 17101 -112 4H/ Ht 170 -10, 150 140a 2109 2100 140b 13 4a113
priorityDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467695922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416013428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92323602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID565677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323431

Total number of triples: 34.